Showing results (381-390 of 399) with videos related to

Sort By:
Pageof 40
Bone Marrow Transplantation|September 4, 2003
A new conditioning regimen involving total marrow irradiation, busulfan and cyclophosphamide followed by autologous PBSCT in patients with advanced multiple myelomaH Einsele, M Bamberg, W Budach, et al.
Journal of Cancer Research and Clinical Oncology|April 11, 2014
Explaining survival differences between two consecutive studies with allogeneic stem cell transplantation in patients with chronic myeloid leukemiaMarkus Pfirrmann, Susanne Saussele, Andreas Hochhaus, et al.
Leukemia|September 11, 2020
Correction: High-risk additional chromosomal abnormalities at low blast counts herald death by CMLRüdiger Hehlmann, Astghik Voskanyan, Michael Lauseker, et al.
Leukemia|May 9, 2020
High-risk additional chromosomal abnormalities at low blast counts herald death by CMLRüdiger Hehlmann, Astghik Voskanyan, Michael Lauseker, et al.
British Journal of Cancer|July 7, 2012
Docetaxel combined with irinotecan or 5-fluorouracil in patients with advanced oesophago-gastric cancer: a randomised phase II studyA Roy, D Cunningham, R Hawkins, et al.
BMC Cancer|December 13, 2006
A randomized multi-center phase II trial of the angiogenesis inhibitor Cilengitide (EMD 121974) and gemcitabine compared with gemcitabine alone in advanced unresectable pancreatic cancerHelmut Friess, Jan M Langrehr, Helmut Oettle, et al.
Annals of Hematology|October 29, 2013
Younger patients with chronic myeloid leukemia do well in spite of poor prognostic indicators: results from the randomized CML study IVLida Kalmanti, Susanne Saussele, Michael Lauseker, et al.
Deutsche Medizinische Wochenschrift (1946)|May 28, 1982
[Bone marrow transplantation for aplastic anaemia and acute leukaemia (author's transl)]U W Schaefer, C G Schmidt, U Rüther, et al.
Seminars in Oncology|May 13, 1998
The use of dose-intensified chemotherapy in the treatment of metastatic nonseminomatous testicular germ cell tumors. German Testicular Cancer Study GroupC Bokemeyer, A Harstrick, J Beyer, et al.
Leukemia|October 3, 2003
Dynamics of BCR-ABL mRNA expression in first-line therapy of chronic myelogenous leukemia patients with imatinib or interferon alpha/ara-CM C Müller, N Gattermann, T Lahaye, et al.
Pageof 40